Back to Search Start Over

Magnesium Sulphate for Eclampsia and Fetal Neuroprotection: A Comparative Analysis of Protocols Across Canadian Tertiary Perinatal Centres

Authors :
Dane De Silva
Graeme Smith
J Mark Ansermino
Laura Gaudet
Bruno Piedboeuf
Rollin Brant
Peter Von Dadelszen
Emmanuel Bujold
Source :
Journal of Obstetrics and Gynaecology Canada. 37:975-987
Publication Year :
2015
Publisher :
Elsevier BV, 2015.

Abstract

Background : Magnesium sulphate (MgSO 4 ) has been recommended for fetal neuroprotection to prevent cerebral palsy, with national societies adopting new guidelines for its use. A knowledge translation project to implement Canadian guidelines is ongoing. Discussion about MgSO 4 for fetal neuroprotection could not occur distinct from MgSO 4 for eclampsia prophylaxis and treatment. Thus, in order to explore standardization of MgSO 4 use in Canada, we sought to compare local protocols for eclampsia and fetal neuroprotection across tertiary perinatal centres. Methods : Twenty-five Canadian tertiary perinatal centres were asked to submit their protocols for use of MgSO 4 for eclampsia prophylaxis/treatment and fetal neuroprotection. Information abstracted included date of protocol, definitions of indications for treatment, details of MgSO 4 administration, maternal and fetal monitoring, antidote for toxicity, and abnormal signs requiring physician attention. Descriptive analyses were used to compare site protocols with known definitions of preeclampsia. Data from the Canadian Perinatal Network (CPN) were used to verify what was done in clinical practice. Results : Twenty-two of the 25 centres submitted protocols for eclampsia prevention/treatment. Eleven of these provided a definition of preeclampsia that warranted treatment; five of the 22 advised treatment of severe preeclampsia only. Criteria for treatment and monitoring procedures varied across centres. Sixteen of the 22 sites with protocols had data from the CPN. Of 635 women with pre-eclampsia, 422 (66 5%) received MgSO 4 Twenty of 25 centres provided protocols for fetal neuroprotection. Definitions of indications were consistent across sites, except for gestational age cut-off. Conclusion : This study suggests that local protocols are often inconsistent with published evidence. While this may be related to local institutional practices, relevant processes must be put in place to maximize uniformity of practice and improve patient care.

Details

ISSN :
17012163
Volume :
37
Database :
OpenAIRE
Journal :
Journal of Obstetrics and Gynaecology Canada
Accession number :
edsair.doi.dedup.....8f32e723f6d1fec598930d16bda5e63b